Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 210-521-7 | CAS number: 617-62-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The LD50 by oral route was determined to be between 300 and 2000 mg/kg.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 2014-05-20 to 2014-08-29
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP study, OECD 423 compliant
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- 06 May 2013
- Test type:
- acute toxic class method
- Limit test:
- no
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
Species: Rat, Wistar strain Crl:WI (Han) (outbred, SPF-Quality). Recognized by international guidelines as the recommended test system (e.g. OECD, EC).
Source: Charles River Deutschland, Sulzfeld, Germany.
Number of animals: 9 Females (nulliparous and non-pregnant). Each dose group consisted of 3 animals.
Age and body weight: Young adult animals (approx. 8-9 weeks old) were selected. Body weight variation did not exceed +/- 20% of the sex mean.
Identification: Earmark and tail mark
Health inspection: At least prior to dosing. It is ensured that the animals were healthy and without any abnormality that might affect the study integrity.
ENVIRONMENTAL CONDITIONS
Conditions
Environmental controls for the animal room were set to maintain 18 to 24°C, a relative humidity of 40 to 70%, at least 10 air changes/hour, and a 12-hour light/12-hour dark cycle. Any variations to these conditions were maintained in the raw data and had no effect on the outcome of the study.
Accommodation
Group housing of 3 animals per cage in labeled Makrolon cages (MIV type; height 18 cm.) containing sterilized sawdust as bedding material (Lignocel S 8-15, JRS - J.Rettenmaier & Söhne GmbH + CO. KG, Rosenberg, Germany) and paper as cage-enrichment (Enviro-dri, Wm. Lillico & Son (Wonham Mill Ltd), Surrey, United Kingdom).
Acclimatization period was at least 5 days before start of treatment under laboratory conditions.
Diet
Free access to pelleted rodent diet (SM R/M-Z from SSNIFF® Spezialdiäten GmbH, Soest, Germany).
Water
Free access to tap water. - Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- Method: Oral gavage, using plastic feeding tubes. Test substance (formulations) were stirred on a magnetic stirrer during dosing.
Fasting: Animals were deprived of food overnight prior to dosing and until 3-4 hours after administration of the test substance. Water was available ad libitum.
Frequency Single dosage on Day 1.
Dose level (volume): 2000 mg/kg (10 mL/kg) body weight.
300 mg/kg (10 mL/kg) body weight. - Doses:
- 300 and 2000 mg/kg
- No. of animals per sex per dose:
- 3 animals at 2000 mg/kg
6 animals at 300 mg/kg - Control animals:
- no
- Details on study design:
- The toxicity of the test substance was assessed by stepwise treatment of groups of 3 females. The first group was treated at a dose level of 2000 mg/kg. The absence or presence of mortality of animals dosed at one step determined the next step, based on the test procedure defined in the guidelines. The onset, duration and severity of the signs of toxicity were taken into account for determination of the time interval between the dose groups.
OBSERVATIONS
Mortality/Viability: Twice daily.
Body weights: Days 1 (pre-administration), 8 and 15 and at death (if found dead after Day 1).
Clinical signs: At periodic intervals on the day of dosing (Day 1) and once daily thereafter, until Day 15. The symptoms were graded according to fixed scales and the time of onset, degree and duration were recorded:
Maximum grade 4: grading slight (1) to very severe (4)
Maximum grade 3: grading slight (1) to severe (3)
Maximum grade 1: presence is scored (1).
Necropsy: The animals surviving to the end of the observation period were sacrificed by oxygen/carbon dioxide procedure. All animals assigned to the study were subjected to necropsy and descriptions of all internal macroscopic abnormalities recorded. - Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 300 - 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- At 2000 mg/kg, two animals were found dead on Day 2.
At 300 mg/kg, no mortality occurred. - Clinical signs:
- other: At 2000 mg/kg, hunched posture and piloerection were noted for all animals between Days 1 and 4 (or until death). At 300 mg/kg, hunched posture and/or piloerection were noted among the animals on Days 1 and/or 2.
- Gross pathology:
- At 2000 mg/kg, abnormalities of the stomach (many reddish foci in the glandular mucosa) and duodenum (many dark red foci) were found at macroscopic post mortem examination in both animals that died during the study.
Macroscopic examination of the animals at 300 mg/kg and the surviving at animal 2000 mg/kg did not reveal any abnormalities - Interpretation of results:
- harmful
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The oral LD50 value of 2-Methylglutaric acid in Wistar rats was established to be within the range of 300-2000 mg/kg body weight.
- Executive summary:
Assessment of acute oral toxicity with 2-Methylglutaric acid in the rat (Acute Toxic Class Method) was realised according to the OECD 423 guideline and under GLP conditions.
Initially, 2-Methylglutaric acid was administered by oral gavage to three female Wistar rats at 2000 mg/kg body weight. In a stepwise procedure two additional groups of three females were dosed at 300 mg/kg body weight. Animals were subjected to daily observations and weekly determination of body weight. Macroscopic examination was performed on the day of death or after terminal sacrifice (Day 15).
At 2000 mg/kg, two animals werefound dead on Day 2.At 300 mg/kg, no mortality occurred.
At 2000 mg/kg, hunched posture and piloerection were noted for all animals between Days 1 and 4 (or until death).
At 300 mg/kg, hunched posture and/or piloerection were noted among the animals on Days 1 and/or 2.
At 2000 mg/kg, abnormalities of the stomach (many reddish foci in the glandular mucosa) and duodenum (many dark red foci) were found at macroscopic post mortem examination in both animals that died during the study. Macroscopic examination of the animals at 300 mg/kg and the surviving animal at 2000 mg/kg did not reveal any abnormalities.
Based on these observations, it is concluded that the death of the two deceased animals is likely to be related to corrosive effects of the substance on the GI tract.
The oral LD50 value of Methylglutaric acid in Wistar rats was established to be within the range of 300-2000 mg/kg body weight.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 300 mg/kg bw
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- other:
Reference
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- other:
Reference
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Oral
Assessment of acute oral toxicity with 2-Methylglutaric acid in the rat (Acute Toxic Class Method) was realised according to the OECD 423 guideline and under GLP conditions.
Initially, 2-Methylglutaric acid was administered by oral gavage to three female Wistar rats at 2000 mg/kg body weight. In a stepwise procedure two additional groups of three females were dosed at 300 mg/kg body weight. Animals were subjected to daily observations and weekly determination of body weight. Macroscopic examination was performed on the day of death or after terminal sacrifice (Day 15).
At 2000 mg/kg, two animals were found dead on Day 2. At 300 mg/kg, no mortality occurred.
At 2000 mg/kg, hunched posture and piloerection were noted for all animals between Days 1 and 4 (or until death).
At 300 mg/kg, hunched posture and/or piloerection were noted among the animals on Days 1 and/or 2.
At 2000 mg/kg, abnormalities of the stomach (many reddish foci in the glandular mucosa) and duodenum (many dark red foci) were found at macroscopic post mortem examination in both animals that died during the study. Macroscopic examination of the animals at 300 mg/kg and the surviving animal at 2000 mg/kg did not reveal any abnormalities.
Based on these observations, it is concluded that the death of the two deceased animals is likely to be related to corrosive effects of the substance on the GI tract.
The oral LD50 value of 2-Methylglutaric acid in Wistar rats was established to be within the range of 300-2000 mg/kg body weight.
Inhalation:
This study was waived. The acute inhalation study does not need to be conducted as the substance is classified as corrosive in contact with the skin and exposure of humans via inhalation is unlikely as the substance is a non-pulverulent solid and non-volatile as evidenced by its vapor pressure ≤ 5.6x10-4 Pa at 20°C. Moreover, generation of droplet or aerosols is not expected in any of the substance expected use.
Dermal:
2-Methylglutaric acid was found corrosive in a Corrositex study (OECD 435) and is classified Skin corrosion Category 1C.
According to the column 2 of the Annex VIII of the Regulation (EC) No. 1907/2006 (REACh) (section 8.5.3), an acute dermal toxicity study does not need to be conducted if the substance is classified as corrosive to the skin. In addition, as mentioned in the Guidance on the application of Regulation (EC) No 1272/2008, a skin corrosive substance is considered to also cause serious eye damage which is indicated in the hazard statement for skin corrosion (H314: causes severe skin burns and eye damage).
Justification for selection of acute toxicity – oral endpoint
GLP study, OECD 423 compliant, quoted Klimish 1 and selected as key study.
Justification for selection of acute toxicity – inhalation endpoint
In accordance with column 2 of REACH Annex VIII, the acute inhalation study does not need to be conducted as the substance is classified as corrosive in contact with the skin, an acute toxicity study is available and no significant exposure is expected as MGA is a non-pulverulent solid and has a low volatility as evidenced by it vapor pressure of 5.6.10-4 Pa at 20°C.
Justification for selection of acute toxicity – dermal endpoint
2-Methylglutaric acid was found corrosive in a Corrositex study (OECD 435) and is classified Skin corrosion Category 1C.
According to the column 2 of the Annex VIII of the Regulation (EC) No. 1907/2006 (REACh) (section 8.5.3), an acute dermal toxicity study does not need to be conducted if the substance is classified as corrosive to the skin.
Justification for classification or non-classification
Based on the acute oral study, with a LD50 between 300 and 2000 mg/kg, 2-Methylglutaric acid is classified as harmful by ingestion (H302), according to the CLP 1272/2008 criteria.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.